New eye implant could slow vision loss from dry AMD
Disease control
Recruiting now
This study tests a biodegradable eye implant called TO-O-1007 for geographic atrophy, a form of advanced dry age-related macular degeneration that causes blind spots. The implant slowly releases medication over 6 months to slow disease progression. About 31 adults aged 50 and old…
Phase: PHASE1, PHASE2 • Sponsor: Theratocular Biotek Co. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC